AFP and hepatocellular carcinoma: The ANOVA analysis and the unpaired t-test comparison demonstrated distinct statistically significant differences in mean serum AFP levels among patients with HCC and those with cirrhosis, compared to the control group (P = 0.0259), with the highest level of AFP reported in the HCC group (88.99 ± 186.9).